Novartis AG (NVS)
140.76
-0.18
(-0.12%)
USD |
NYSE |
Oct 06, 16:00
140.81
+0.06
(+0.04%)
After-Hours: 18:31
Novartis Price : 140.76 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 05, 2026 | 141.02 | 141.02 | 139.31 | 140.93 | 1.329M |
| Oct 02, 2026 | 141.46 | 141.57 | 139.95 | 141.00 | 2.247M |
| Oct 01, 2026 | 142.22 | 142.50 | 140.87 | 141.05 | 2.056M |
| Sep 30, 2026 | 145.39 | 145.50 | 142.56 | 142.57 | 3.062M |
| Sep 29, 2026 | 144.81 | 146.18 | 144.46 | 145.71 | 1.599M |
| Sep 28, 2026 | 145.77 | 147.03 | 145.72 | 146.88 | 1.949M |
| Sep 25, 2026 | 144.57 | 145.51 | 144.00 | 145.46 | 1.166M |
| Sep 24, 2026 | 143.00 | 144.66 | 142.91 | 143.57 | 1.888M |
| Sep 23, 2026 | 143.15 | 143.94 | 142.02 | 142.71 | 2.518M |
| Sep 22, 2026 | 141.26 | 141.80 | 140.00 | 141.28 | 1.544M |
| Sep 21, 2026 | 141.96 | 142.18 | 140.96 | 140.98 | 1.554M |
| Sep 18, 2026 | 140.87 | 141.15 | 139.60 | 140.37 | 2.248M |
| Sep 17, 2026 | 140.12 | 141.21 | 139.97 | 140.92 | 1.714M |
| Sep 16, 2026 | 140.58 | 141.46 | 138.28 | 138.70 | 1.892M |
| Sep 15, 2026 | 138.76 | 139.11 | 137.37 | 138.62 | 2.367M |
| Sep 14, 2026 | 141.64 | 141.64 | 138.99 | 138.99 | 2.480M |
| Sep 11, 2026 | 139.31 | 139.55 | 137.00 | 137.16 | 2.354M |
| Sep 10, 2026 | 138.76 | 139.43 | 137.46 | 137.48 | 2.420M |
| Sep 09, 2026 | 138.14 | 139.45 | 137.30 | 137.48 | 2.937M |
| Sep 08, 2026 | 139.94 | 140.46 | 137.12 | 137.70 | 10.27M |
| Sep 04, 2026 | 159.90 | 160.93 | 159.62 | 159.99 | 1.294M |
| Sep 03, 2026 | 164.48 | 164.48 | 161.42 | 163.09 | 2.453M |
| Sep 02, 2026 | 160.80 | 163.18 | 160.38 | 162.46 | 4.344M |
| Sep 01, 2026 | 162.15 | 163.57 | 160.21 | 161.25 | 4.335M |
| Aug 31, 2026 | 152.60 | 152.74 | 151.68 | 152.06 | 1.286M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Roche Holding AG | 52.51 |
| AstraZeneca PLC | 158.58 |
| GSK Plc | 46.60 |
| Johnson & Johnson | 254.78 |
| Eli Lilly & Co. | 1157.35 |
Price Related Metrics
| PE Ratio | 21.23 |
| PS Ratio | 4.944 |
| Price to Book Value | 6.202 |
| Price to Free Cash Flow | 18.07 |
| Earnings Yield | 4.71% |
| Market Cap | 257.66B |
| Operating PE Ratio | 16.72 |
| Normalized PE Ratio | 19.78 |